Cargando…
Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259909/ https://www.ncbi.nlm.nih.gov/pubmed/35794721 http://dx.doi.org/10.3947/ic.2022.0045 |
| _version_ | 1784741892437573632 |
|---|---|
| author | Seo, Hyeonji Chong, Yong Pil |
| author_facet | Seo, Hyeonji Chong, Yong Pil |
| author_sort | Seo, Hyeonji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9259909 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92599092022-07-18 Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 Seo, Hyeonji Chong, Yong Pil Infect Chemother Correspondence The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022-06 2022-06-15 /pmc/articles/PMC9259909/ /pubmed/35794721 http://dx.doi.org/10.3947/ic.2022.0045 Text en Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Seo, Hyeonji Chong, Yong Pil Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title | Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title_full | Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title_fullStr | Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title_full_unstemmed | Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title_short | Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 |
| title_sort | reply: correspondence on fluvoxamine treatment of patients with symptomatic covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259909/ https://www.ncbi.nlm.nih.gov/pubmed/35794721 http://dx.doi.org/10.3947/ic.2022.0045 |
| work_keys_str_mv | AT seohyeonji replycorrespondenceonfluvoxaminetreatmentofpatientswithsymptomaticcovid19 AT chongyongpil replycorrespondenceonfluvoxaminetreatmentofpatientswithsymptomaticcovid19 |